Statin use and the presence of microalbuminuria. Results from the ERICABEL trial: a non-interventional epidemiological cohort study.

<h4>Background</h4>Microalbuminuria (MAU) is considered as a predictor or marker of cardiovascular and renal events. Statins are widely prescribed to reduce cardiovascular risk and to slow down progression of kidney disease. But statins may also generate tubular MAU. The current observat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arjan van der Tol, Wim Van Biesen, Steven Van Laecke, Kris Bogaerts, Koen De Lombaert, Hans Warrinnier, Raymond Vanholder
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3003a43713334de682f2019fb67f4a28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!